Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Acthar low dose (40 U)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49
2Administration of a low dose of desipramine1件: Desipramine2件: D00812 ,
D07791
2件: SLC6A2,
SLC6A4 💬
2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156
3Ambrisentan - low dose1件: Ambrisentan1件: D07077 1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
4AXO-AAV-GM2 Low Dose----1件: 19
5BI 655064 low dose----1件: 46
6BIIL 284 BS low dose----1件: 46
7BIIL 284 BS, low dose----1件: 299
8BIIL 284 BS, low dose, adult patients----1件: 299
9BIIL 284 BS, low dose, pediatric patients----1件: 299
10BIRB 796 BS, low dose----1件: 46
11BLI-1300 low dose----1件: 96
12Brazikumab low dose1件: Brazikumab1件: D10912 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96
13Clobazam Low Dose1件: Clobazam1件: D01253 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144
14CVN424 Low Dose----1件: 6
15CVT-301 Low Dose----1件: 6
16Cyclosporin, low dose steroid1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
17Elamipretide (low dose)1件: Elamipretide1件: D10925 --1件: 21
18EUR-1008 (APT-1008) Low Dose----1件: 298
19Fentanyl (Low Dose)1件: Fentanyl2件: D00320 ,
D01399
1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
20Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl
4件: D00320 ,
D00514 ,
D01205 ,
D01399
4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬
4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215
21HMPL-004 low dose----1件: 97
22IgPro20 (low dose)----1件: 14
23Iloprost low dose1件: Iloprost1件: D02721 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51
24KPS-0373, Low dose----1件: 18
25KW-6356 Low Dose----1件: 6
26Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP5件: Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone
18件: D00385 ,
D00472 ,
D00592 ,
D00752 ,
D00980 ,
D00981 ,
D00982 ,
D00983 ,
D00984 ,
D00985 ,
D01239 ,
D01998 ,
D02156 ,
D03301 ,
D05094 ,
D05095 ,
D05096 ,
D06216
3件: IMPDH1,
IMPDH2,
NR3C1 💬
4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 162
27LiRIS low dose and LiRIS high dose----1件: 226
28Low dose----1件: 97
29Low dose AFFITOPE® PD03A + Adjuvant----1件: 6
30Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day1件: Vitamin D---1件: 13
31Low Dose Aspirin (162 mg/day)1件: Acetylsalicylic acid (Synonym: Childrens Low Dose Aspirin)1件: D00109 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
32Low dose BIBF 1120 twice daily----1件: 85
33Low dose BIBF1120 once daily----1件: 85
34Low Dose Budesonide1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
35Low dose budesonide tablet1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
36Low dose cannabis1件: Medical Cannabis---1件: 13
37Low dose levodopa1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
38Low Dose Mesenchymal Stem Cells (MSCs)----1件: 49
39Low Dose MT-1303----1件: 97
40Low dose naltrexone1件: Naltrexone2件: D02095 ,
D05113
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97
41Low dose of BIIL 284 BS tablets----1件: 46
42Low dose ORTD-1----1件: 46
43Low dose prednisolone1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
44Low dose TSO----1件: 96
45Low dose vehicle control----1件: 46
46Low Dose-VIS649----1件: 66
47LX3305 low dose----1件: 46
48M5049 low dose----1件: 49
49MEDI7183 low dose----1件: 97
50MMX Mesalamine/Mesalazine (Low Dose)1件: Mesalazine1件: D00377 --1件: 97
51MT-1303 Low dose----1件: 49
52MT-7117 Low Dose----1件: 254
53MultiStem low dose1件: MultiStem---1件: 97
54Mycophenolate mofetil, low dose steroid2件: Mycophenolate mofetil,
Mycophenolic acid
4件: D00752 ,
D05094 ,
D05095 ,
D05096
2件: IMPDH1,
IMPDH2 💬
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬1件: 222
55OCU400 Low Dose----1件: 90
56Other: Low dose (1 mcg) ACTH stimulation test1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 193
57PF-06649751 low dose (1 mg QD)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬
10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
58Prednisone, low dose rituximab2件: Prednisone,
Rituximab
2件: D00473 ,
D02994
2件: MS4A1,
NR3C1 💬
2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61
59PXT3003 Low dose----1件: 10
60Ravicti low dose1件: Glycerol phenylbutyrate1件: D10127 --1件: 299
61SA001 Low dose----1件: 53
62SEN0014196 (Low Dose)----1件: 8
63SHR1459 Low Dose----1件: 222
64TAS5315 low dose----1件: 46
65Tiotropium bromide-low dose-2.5mcg1件: Tiotropium---1件: 299
66Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)2件: Methylprednisolone,
Ursodeoxycholic acid
7件: D00407 ,
D00734 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002
2件: NR1H4,
NR3C1 💬
2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93
67YRA-1909 low dose----1件: 46